Alirocumab can address unmet needs in pediatric familial hypercholesterolemia: GlobalData EP News Bureau Feb 20, 2024 Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that…
